AKAN Akanda Corp. logo

AKAN Akanda Corp.

Healthcare
$27.12+15.60%ClosedMarket Cap: $877,766

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.28

P/S

2.44

EV/EBITDA

0.51

DCF Value

$-481.61

FCF Yield

-286.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

73.3%

Operating Margin

-978.8%

Net Margin

-619.5%

ROE

-58.8%

ROA

-35.9%

ROIC

-95.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q2 null$0.00$-815.0K$
Q4 null$359.7K$-1.4M$
FY null$836.7K$-4.1M$
Q2 null$477.0K$-2.7M$

Trading Activity

Insider Trades

View All
HRT FINANCIAL LP10 percent owner
SellTue Jan 20
HRT FINANCIAL LP10 percent owner
BuyTue Jan 20
HRT FINANCIAL LP10 percent owner
SellTue Jan 20

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

GB

Exchange

Beta

1.73

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Peers